COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,871 Articles (22,568 medRxiv, 8,303 bioRxiv)

Most recent first Previous |  Page 1402: Articles 14011-14020  | Next

Seroprevalence of COVID-19 in HIV Population
Naik, S. R., Kumar, S. S., Mittal, A., Swain, S., Ranjan, S., Soneja, M., Sinha, S., Nischal, N., Jorwal, P., Chaturvedi, P. K., Wig, N.
10.1101/2021.06.17.21259066 — Posted: 2021-06-20
A Short Plus Long-Amplicon Based Sequencing Approach Improves Genomic Coverage and Variant Detection In the SARS-CoV-2 Genome
Arana, C., Liang, C., Brock, M., Zhang, B., Zhou, J., Chen, L., Cantarel, B., SoRelle, J., Hooper, L. V., Raj, P.
10.1101/2021.06.16.21259029 — Posted: 2021-06-20
Rapid spread of the SARS-CoV-2 δ variant in the area of Paris (France) in June 2021
Alizon, S., Haim-Boukobza, S., Foulongne, V., Verdurme, L., Trombert-Paolantoni, S., Lecorche, E., Roquebert, B., Sofonea, M. T.
10.1101/2021.06.16.21259052 — Posted: 2021-06-20
COVID-19 Transmission Dynamics Underlying Epidemic Waves in Kenya
Brand, S. P. C., Ojal, J., Aziza, R., Were, V., Okiro, E., Kombe, I., Mburu, C., Ogero, M., Agweyu, A., Warimwe, G. M., Nyagwange, J., Karanja, H., Gitonga, J., Mugo, D., Uyoga, S., Adetifa, I. M. O., Scott, J. A. G., Otieno, E., Murunga, N., Otiende, M., Ochola-Oyier, L. I., Agoti, C. N., Githinji, G., Kasera, K., Amoth, P., Mwangangi, M., Aman, R., Ng'ang'a, W., Tsofa, B., Bejon, P., Keeling, M. J., Nokes, D. J., Barasa, E.
10.1101/2021.06.17.21259100 — Posted: 2021-06-20
Understanding the Potential Impact of Different Drug Properties On SARS-CoV-2 Transmission and Disease Burden: A Modelling Analysis
Whittaker, C., Watson, O., Alvarez-Moreno, C., Angkasekwinai, N., Boonyasiri, A., Carlos-Triana, L., Chanda, D., Charoenpong, L., Chayakulkeeree, M., Cooke, G., Croda, J., Cucunuba, Z., Djafaara, B., Estofolete, C., Eugenia-Grillet, M., Faria, N., Figueiredo-Costa, S., Forero-Pena, D., Gibb, D., Gordon, A., Hamers, R., Hamlet, A., Irawany, V., Jitmuang, A., Keurueangkul, N., Kimani, T. N., Lampo, M., Levin, A., Lopardo, G., Mustafa, R., Nayagam, S., Ngamprasertchai, T., Njeri, N. I. H., Nogueira, M., Ortiz-Prado, E., Perroud, M., Phillips, A., Promsin, P., Qavi, A., Rodger, A., Sabino, E., Sangkaew, S., Sari, D., Sirijatuphat, R., Sposito, A., Srisangthong, P., Thompson, H., Udwadia, Z., Valderrama-Beltran, S., Winskill, P., Ghani, A., Walker, P., Hallett, T.
10.1101/2021.06.17.21259078 — Posted: 2021-06-20
Determination of IgG1 and IgG3 SARS-CoV-2 spike protein and nucleocapsid binding. Who is binding who and why?
Iles, J. K., Zmuidinaite, R., Sadee, C., Gardiner, A., Lacey, J., Harding, S., Wallis, G., Patel, R., Roblett, D., Heeney, J. L., Baxendale, D. H., Iles, R. K.
10.1101/2021.06.17.21259077 — Posted: 2021-06-20
Evaluation of the Access Bio CareStartTM rapid SARS-CoV-2 antigen test in asymptomatic individuals tested at a community mass-testing program in Western Massachusetts
Suliman, S., Matias, W. R., Fulcher, I. R., Molano, F. J., Collins, S., Uceta, E., Zhu, J., Paxton, R. M., Gonsalves, S. F., Harden, M. V., Fisher, M., Meldrim, J., Gabriel, S., Franke, M. F., Hung, D., Smole, S. C., Madoff, L. C., Ivers, L. C.
10.1101/2021.06.17.21259109 — Posted: 2021-06-20
Prevalence evolution of SARS-CoV-2 infection in the Municipality of Sao Paulo, 2020 - 2021
Albuquerque, J. O. M. d., Kamioka, G. A., Madalosso, G., Costa, S. A., Ferreira, P. B., Pino, F. A., Sato, A. P. S., Carvalho, A. C. A. d., Amorim, A. B. P., Aires, C. C., Kataoka, A. P. A. G., Savani, E. S. M. M., Bessa, T. A. F., Aguiar, B. S. d., Failla, M. A., Santos, E. A. d., Brito, E. M. T., Santos, M. C. H. d., Silva, S. M. S. e., Caldeira, L. A. V., Zamarco, L. C., Fonseca, S. M. S., Lima, M. M. d. C., Marques, I. A., Silva, F. E. V. d., Glasser, P. R., Burihan, P. C. P. R., Cavazzana, C. L., Lara, R. C., Mello, D. S. d., Pellini, A. C. G., Nishio, F. Y., Kian, F. M., Braga, E. d. S., Bertelli, N. M. P., Fracini, W., Goncalves, M. D. A., Zular, P. S., Piva, R. d. S., Masi, E. d.
10.1101/2021.06.16.21256530 — Posted: 2021-06-20
Mutations within the Open Reading Frame (ORF) including Ochre stop codon of the Surface Glycoprotein gene of SARS-CoV-2 virus erase potential seed location motifs of human non-coding microRNAs.
Goyani, K. H., Vaniawala, S., Mukhopadhyaya, P. N.
10.1101/2021.06.19.449095 — Posted: 2021-06-19
The percentage of Monocytes CD39+ is higher in Pregnant COVID-19 than in Non-Pregnant COVID-19 patients
Cerbulo-Vazquez, A., Garcia-Espinosa, M., Briones-Garduno, J. C., Arriaga-Pizano, L. A., Ferat-Osorio, E., Zavala-Barrios, B., Cabrera-Rivera, G. L., Miranda-Cruz, P., Garcia de la Rosa, M. T., Prieto-Chavez, J. L., Rivero-Arredondo, V., Madera-Sandoval, R. L., Cruz-Cruz, A., Salazar-Rios, E., Salazar-Rios, M. E., Serrano-Molina, D., De Lira-Barraza, R. C., Villanueva-Compean, A. H., Esquivel-Pineda, A., Ramirez-Montes de Oca, R., Caldino-Soto, F., Ramirez-Garcia, L. A., Flores-Padilla, M. G., Moreno-Alvarez, O., Guerrero-Avendano, G. M. L., Lopez-Macias, C.
10.1101/2021.06.18.449054 — Posted: 2021-06-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).